Understanding the Why: The Compliance Behind Engaging with HCPs
Life science organizations are dedicated to developing and manufacturing transformative products that enhance lives. To accomplish this mission, they routinely contract with healthcare professionals (HCPs) to research, develop, market and train on these products. HCPs contribute invaluable insights, expertise and medical credibility by providing both a theoretical and practical approach to the products and treatments. [...]
Top 10 Tips and Tricks for Remediating Data Issues and Reporting Your Transparency Data
Life sciences professionals engaged in transparency reporting understand the myriad of challenges in compiling necessary data for reporting. Navigating challenges such as incomplete records, discrepancies among data sources, duplicate, or late data submissions can significantly compromise the accuracy of reporting. Compliance and transparency teams often endure heightened stress and sleepless nights over these common issues, [...]
Navigating Recent Global Legislative Updates in the Life Science Industry
MediSpend’s legal experts recently presented a webinar shedding light on the recent transparency updates within the life science industry. The presentation covered key topics, such as updates to CMS’ Open Payments reporting, various state considerations and the newly issued OIG General Compliance Program Guidance. Notably, the webinar highlighted recent developments in compliance regulations in both Italy and [...]
Legislative Watch Update (Jan 2024)
For pharmaceutical and medical device manufacturers of all sizes, it is important to stay on top of the latest transparency reporting regulations and HCP/O engagement rules. As a leading provider of transparency reporting and paid HCP engagement management solutions, MediSpend also offers our Legislative Watch to help keep you up-to-date on related legislation. In [...]
Overcoming Transparency Reporting Challenges Webcast
MediSpend's Chief Commercial Officer, Seth Houston, walks through the top six transparency reporting challenges and provides solutions to overcome those challenges.
OIG Issues General Compliance Program Guidance
On November 6, 2023, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG), in connection with the November 2023 Health Care Compliance Association’s (HCCA) Healthcare Enforcement Compliance Conference, published the General Compliance Program Guidance (GCPG) as a revised reference guide for the healthcare compliance community and other healthcare stakeholders. During [...]
Legislative Watch Updates
MediSpend’s Advisory Services team recently presented a webinar on emerging transparency updates and requirements for pharmaceutical and medical device manufacturers. Notable updates included changes to the Centers for Medicare & Medicaid Services (CMS) Open Payments reporting, Connecticut’s new sales representative disclosure requirements and an update on the Italian Sunshine Act. CMS Open Payments Updates Numerous [...]
CMS Publishes 2022 Open Payments Data
The Centers for Medicare and Medicaid Services (CMS) recently published their 2022 Open Payments data as well as newly submitted and updated payment records for previous program years. The 2022 publication includes transactions that took place between January 1st and December 31st. Applicable manufacturers reported $12.59 billion in reportable payments, ownership and investment interests to [...]
Getting Ahead of Transparency Reporting Webcast
MediSpend's Suj Patel and Frank Madden discuss ways to get and stay ahead of global transparency reporting obligations.
Sanctions Screening Service is a Win-Win for Life Sciences Organizations
Life sciences organizations are subject to numerous legal and regulatory requirements, including an obligation to screen the healthcare professionals and organizations (HCP/Os) that they contract and engage with to ensure they are not caught off guard by any infractions that exist, a process known as sanctions screening. Sanctions screening involves verifying these individuals and entities [...]
[su_posts posts_per_page=”15″ tax_term=”177″ tax_operator=”0″ order=”desc”]